Literature DB >> 11899422

Inhibition of human T-cell responses by allergen peptides.

M Larché1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11899422      PMCID： PMC1783330          DOI： 10.1046/j.1365-2567.2001.01293.x

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  34 in total

1.  Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat.

Authors:  C M Counsell; J F Bond; J L Ohman; J L Greenstein; R D Garman
Journal:  J Allergy Clin Immunol       Date:  1996-11       Impact factor: 10.793

2.  Effects of peptide therapy on ex vivo T-cell responses.

Authors:  G V Marcotte; C M Braun; P S Norman; C F Nicodemus; A Kagey-Sobotka; L M Lichtenstein; D M Essayan
Journal:  J Allergy Clin Immunol       Date:  1998-04       Impact factor: 10.793

3.  Human T and B cell immune responses to Fel d 1 in cat-allergic and non-cat-allergic subjects.

Authors:  P G Mark; D B Segal; M L Dallaire; R D Garman
Journal:  Clin Exp Allergy       Date:  1996-11       Impact factor: 5.018

4.  Short peptide-based tolerogens without self-antigenic or pathogenic activity reverse autoimmune disease.

Authors:  N Karin; O Binah; N Grabie; D J Mitchell; B Felzen; M D Solomon; P Conlon; A Gaur; N Ling; L Steinman
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

5.  Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1.

Authors:  L Bauer; B Bohle; B Jahn-Schmid; U Wiedermann; A Daser; H Renz; D Kraft; C Ebner
Journal:  Clin Exp Immunol       Date:  1997-03       Impact factor: 4.330

6.  Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects.

Authors:  F E Simons; M Imada; Y Li; W T Watson; K T HayGlass
Journal:  Int Immunol       Date:  1996-12       Impact factor: 4.823

7.  Treatment of cat allergy with T-cell reactive peptides.

Authors:  P S Norman; J L Ohman; A A Long; P S Creticos; M A Gefter; Z Shaked; R A Wood; P A Eggleston; K B Hafner; P Rao; L M Lichtenstein; N H Jones; C F Nicodemus
Journal:  Am J Respir Crit Care Med       Date:  1996-12       Impact factor: 21.405

8.  Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.

Authors:  C A Akdis; M Akdis; T Blesken; D Wymann; S S Alkan; U Müller; K Blaser
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

9.  Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats.

Authors:  J Pène; A Desroches; L Paradis; B Lebel; M Farce; C F Nicodemus; H Yssel; J Bousquet
Journal:  J Allergy Clin Immunol       Date:  1998-10       Impact factor: 10.793

10.  Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.

Authors:  U Müller; C A Akdis; M Fricker; M Akdis; T Blesken; F Bettens; K Blaser
Journal:  J Allergy Clin Immunol       Date:  1998-06       Impact factor: 10.793
View more
  4 in total

Review 1.  Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?

Authors:  M Peakman; C M Dayan
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

2.  L.E.A.P.S. heteroconjugate is able to prevent and treat experimental autoimmune myocarditis by altering trafficking of autoaggressive cells to the heart.

Authors:  Daniela Cihakova; Jobert G Barin; G Christian Baldeviano; Miho Kimura; Monica V Talor; Daniel H Zimmerman; Eyal Talor; Noel R Rose
Journal:  Int Immunopharmacol       Date:  2008-01-29       Impact factor: 4.932

3.  PeptX: using genetic algorithms to optimize peptides for MHC binding.

Authors:  Bernhard Knapp; Verena Giczi; Reiner Ribarics; Wolfgang Schreiner
Journal:  BMC Bioinformatics       Date:  2011-06-17       Impact factor: 3.169

4.  14-3-3ζ-A Novel Immunogen Promotes Inflammatory Cytokine Production.

Authors:  Jenna McGowan; Cara Peter; Saurabh Chattopadhyay; Ritu Chakravarti
Journal:  Front Immunol       Date:  2019-07-24       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.